Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of asthma
Reversibility of at least 12% and at least 200mLs within 10-40 minutes following 2-4 inhalations of albuterol
FEV1 of 40-85% predicted normal
Currently using inhaled corticosteroid therapy
You may not be if
History of life-threatening asthma within previous 5 years (requiring intubation and/or was associated with hypercapnoea, respiratory arrest or hypoxic seizures)
Respiratory infection or oral candidiasis
Asthma exacerbation requiring oral corticosteroids or that resulted in overnight hospitalisation requiring additional asthma treatment
Uncontrolled disease or clinical abnormality
Allergies
Taking another investigational medication or prohibited medication
Night shift workers
Current smokers or subjects with smoking history of at least 10 pack years
Clareo Health | HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents
